WeVote
Log In

Bill

Bill

HB 4469

DHS-AFFORDABLE GENERIC DRUGS

104th Regular Session Introduced by Hoan Huynh

Illinois DHS creates generic drug affordability programs for Medicaid to reduce prescription costs through increased utilization of lower-cost alternatives.

0
WeVote Research Nonpartisan
Bill Summary · HB 4469

Legislative bill overview

HB 4469 directs the Illinois Department of Human Services (DHS) to establish or expand programs promoting the use and affordability of generic drugs for Medicaid and state-funded health programs. The bill aims to reduce prescription drug costs by increasing generic drug utilization among eligible beneficiaries through various mechanisms that DHS would determine.

Why is this important

Generic drugs typically cost 80-85% less than brand-name equivalents, making this directly relevant to state healthcare budgets and patient out-of-pocket expenses. Illinois's Medicaid program serves over 3 million residents, so policies affecting drug costs have substantial fiscal and public health implications for the state.

Potential points of contention

  • Implementation ambiguity: The bill provides DHS significant discretion without specifying which programs, incentive structures, or populations would be targeted, raising questions about actual program scope and effectiveness
  • Cost-benefit analysis: No fiscal impact statement details whether savings would exceed administrative costs of establishing new programs or infrastructure changes required
  • Pharmacy/prescriber concerns: Mandatory generic substitution policies can face resistance from pharmacies worried about margins and physicians concerned about clinical judgment restrictions, potentially affecting implementation feasibility

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.